Management of cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia using prostaglandin E1 and aspirin.
Shorten
G
G
Department of Anesthesia and Critical Care, Harvard Medical School Boston, MA 02215.
Comunale
M E
ME
Johnson
R G
RG
D000368:Aged; D000527:Alprostadil / Q000008:administration & dosage / Q000627:therapeutic use*; D000789:Angina, Unstable / Q000188:drug therapy; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use*; D002315:Cardiopulmonary Bypass; D001026:Coronary Artery Bypass; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D007430:Intraoperative Care; D009203:Myocardial Infarction / Q000188:drug therapy; D010974:Platelet Aggregation / Q000187:drug effects; D011300:Preoperative Care; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy*
D006493:Heparin; D000527:Alprostadil; D001241:Aspirin